Purpose: Due to a lack of science-based evidence, we explored the effects of exposure to intermediate frequency magnetic fields (IF-MF) on experimental animals. We assessed several immunological parameters to determine the effect of exposure of the whole body to IF-MF.

Materials And Methods: Male Sprague-Dawley rats (4-5 weeks old) were divided into three groups: Cage-control, sham, and 3.8-mT (rms) exposure groups. The animals were exposed to IF-MF at 21 kHz under fixed conditions in an acrylic holder. Exposure was performed for 1 h/day for 14 consecutive days. On the 15th day following the exposure, biochemical and hematological parameters in blood were analyzed. The effects of the exposure on immunological functions such as the cytotoxic activity of lymphocytes, chemotactic and phagocytic activity of granulocytes, and T (cluster of differentiation 4 [CD4] and cluster of differentiation 8 [CD8])-cell frequency were also examined.

Results: Hematological parameters were not affected by IF-MF exposure. Other immune functions such as the cytotoxic activity and phagocytic activity were not affected. Populations of T cells after exposure also did not show any significant differences. In blood biochemistry, there was significant difference in inorganic phosphorus level between sham and exposure group. However, this will not induce any pathophysiological status, because they were still within physiological range. Overall, no significant effect by exposure of IF-MF was observed under our experimental conditions.

Conclusions: Our results suggest that exposure to 21-kHz sinusoidal IF-MF at 3.8 mT for 1 h/day for 14 days did not affect immune function in juvenile rats.

Download full-text PDF

Source
http://dx.doi.org/10.3109/09553002.2014.930538DOI Listing

Publication Analysis

Top Keywords

exposure
11
intermediate frequency
8
frequency magnetic
8
magnetic fields
8
juvenile rats
8
effects exposure
8
hematological parameters
8
functions cytotoxic
8
cytotoxic activity
8
phagocytic activity
8

Similar Publications

Purpose: This study aims to explore the relationship between autoimmune rheumatic diseases (ARDs) and the risk of iridocyclitis (IC) using Mendelian randomization (MR) analysis.

Methods: Data of ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), Behcet's disease (BD), and iridocyclitis were obtained from genome-wide association studies with large sample sizes. The instrumental variable utilized in this study for each exposure was the single nucleotide polymorphism.

View Article and Find Full Text PDF

In regulatory aquatic risk assessment, toxicokinetic-toxicodynamic (TKTD) methods, such as the generalized unified threshold model of survival (GUTS), are already established and considered ready for use, whereas TKTD methods for aboveground terrestrial species, like arthropods, are less developed and currently not intended for risk assessment. This could be due to the fact that exposure in aboveground terrestrial systems is more event-based (feeding, contact, overspray, etc.), whereas exposure in aquatic systems is simply related to substance concentrations in the surrounding water.

View Article and Find Full Text PDF

Research progress of femoral head necrosis in HIV-infected patients.

Ann Med

December 2025

Department of Joint and Sports Medicine, Zhongnan Hospital, Wuhan University, Wuhan, China.

As life expectancy among patients infected with the human immunodeficiency virus (HIV) increases, a growing number of complications have been observed. This population displays an elevated risk of ischemic necrosis of the femoral head in comparison to the general population, which may be attributed to HIV infection, antiretroviral medication use, and hormone application. Patients infected with the human immunodeficiency virus (HIV) who also have necrosis of the femoral head tend to present at an earlier age, with a rapid disease progression and a high incidence of bilateral onset.

View Article and Find Full Text PDF

Inflammation and Occlusive Retinal Vasculitis Post Faricimab.

JAMA Ophthalmol

January 2025

Truhlsen Eye Center, Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha.

Importance: Randomized clinical trials have shown the safety and efficacy of faricimab as a novel vascular endothelial growth factor and angiopoietin-2 inhibitor in the treatment of neovascular age-related macular degeneration (nAMD) and macular edema of various etiologies. However, more rare adverse events may not be considered in clinical trials.

Objective: To describe 3 eyes that developed irreversible vision loss following initial mild intraocular inflammation (IOI) to faricimab.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!